COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications

Research output: Contribution to journal › Review › Research › peer-review

Standard

COVID-19 associated atrial fibrillation : Incidence, putative mechanisms and potential clinical implications. / Gawalko, Monika; Kaplon-Cieslicka, Agnieszka; Hohl, Mathias; Dobrev, Dobromir; Linz, Dominik.

In: IJC Heart and Vasculature, Vol. 30, 100631, 2020.

Research output: Contribution to journal › Review › Research › peer-review

Harvard

Gawalko, M, Kaplon-Cieslicka, A, Hohl, M, Dobrev, D & Linz, D 2020, 'COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications', IJC Heart and Vasculature, vol. 30, 100631. https://doi.org/10.1016/j.ijcha.2020.100631

APA

Gawalko, M., Kaplon-Cieslicka, A., Hohl, M., Dobrev, D., & Linz, D. (2020). COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications. IJC Heart and Vasculature, 30, [100631]. https://doi.org/10.1016/j.ijcha.2020.100631

Vancouver

Gawalko M, Kaplon-Cieslicka A, Hohl M, Dobrev D, Linz D. COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications. IJC Heart and Vasculature. 2020;30. 100631. https://doi.org/10.1016/j.ijcha.2020.100631

Author

Gawalko, Monika ; Kaplon-Cieslicka, Agnieszka ; Hohl, Mathias ; Dobrev, Dobromir ; Linz, Dominik. / COVID-19 associated atrial fibrillation : Incidence, putative mechanisms and potential clinical implications. In: IJC Heart and Vasculature. 2020 ; Vol. 30.

Bibtex

@article{2f83bc5aacf04d14a83bfe1dcad09589,
title = "COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications",
abstract = "Coronavirus disease 2019 (COVID-19) is a novel, highly transmittable and severe strain disease, which has rapidly spread worldwide. Despite epidemiological evidence linking COVID-19 with cardiovascular diseases, little is known about whether and how COVID-19 influences atrial fibrillation (AF), the most prevalent arrhythmia in clinical practice. Here, we review the available evidence for prevalence and incidence of AF in patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and discuss disease management approaches and potential treatment options for COVID-19 infected AF patients. (C) 2020 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).",
keywords = "Anticoagulation, Arrhythmia, Inflammasome, Remote monitoring, Thromboembolic risk, OBSTRUCTIVE RESPIRATORY EVENTS, CRITICALLY-ILL PATIENTS, INFLAMMATION, PROMOTES, RECEPTOR, OUTCOMES, ACE2, ARRHYTHMIAS, DYSFUNCTION, AMIODARONE",
author = "Monika Gawalko and Agnieszka Kaplon-Cieslicka and Mathias Hohl and Dobromir Dobrev and Dominik Linz",
year = "2020",
doi = "10.1016/j.ijcha.2020.100631",
language = "English",
volume = "30",
journal = "IJC Heart and Vasculature",
issn = "2352-9067",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - COVID-19 associated atrial fibrillation

T2 - Incidence, putative mechanisms and potential clinical implications

AU - Gawalko, Monika

AU - Kaplon-Cieslicka, Agnieszka

AU - Hohl, Mathias

AU - Dobrev, Dobromir

AU - Linz, Dominik

PY - 2020

Y1 - 2020

N2 - Coronavirus disease 2019 (COVID-19) is a novel, highly transmittable and severe strain disease, which has rapidly spread worldwide. Despite epidemiological evidence linking COVID-19 with cardiovascular diseases, little is known about whether and how COVID-19 influences atrial fibrillation (AF), the most prevalent arrhythmia in clinical practice. Here, we review the available evidence for prevalence and incidence of AF in patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and discuss disease management approaches and potential treatment options for COVID-19 infected AF patients. (C) 2020 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

AB - Coronavirus disease 2019 (COVID-19) is a novel, highly transmittable and severe strain disease, which has rapidly spread worldwide. Despite epidemiological evidence linking COVID-19 with cardiovascular diseases, little is known about whether and how COVID-19 influences atrial fibrillation (AF), the most prevalent arrhythmia in clinical practice. Here, we review the available evidence for prevalence and incidence of AF in patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and discuss disease management approaches and potential treatment options for COVID-19 infected AF patients. (C) 2020 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

KW - Anticoagulation

KW - Arrhythmia

KW - Inflammasome

KW - Remote monitoring

KW - Thromboembolic risk

KW - OBSTRUCTIVE RESPIRATORY EVENTS

KW - CRITICALLY-ILL PATIENTS

KW - INFLAMMATION

KW - PROMOTES

KW - RECEPTOR

KW - OUTCOMES

KW - ACE2

KW - ARRHYTHMIAS

KW - DYSFUNCTION

KW - AMIODARONE

U2 - 10.1016/j.ijcha.2020.100631

DO - 10.1016/j.ijcha.2020.100631

M3 - Review

C2 - 32904969

VL - 30

JO - IJC Heart and Vasculature

JF - IJC Heart and Vasculature

SN - 2352-9067

M1 - 100631

ER -

ID: 251588892